First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 0.7281 USD 4.01% Market Closed
Updated: Mar 29, 2024

Relative Value

The Relative Value of one BNR stock under the Base Case scenario is 7.8834 USD. Compared to the current market price of 0.7281 USD, Burning Rock Biotech Ltd is Undervalued by 91%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNR Relative Value
Base Case
7.8834 USD
Undervaluation 91%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
88
Median 3Y
3.7
Median 5Y
4.6
Industry
8.2
Forward
0.8
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.6
Industry
26
Forward
-1.2
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.2
Industry
21.5
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.2
Industry
24.3
vs History
95
vs Industry
71
Median 3Y
1.8
Median 5Y
2.1
Industry
2.7
vs History
vs Industry
84
Median 3Y
2.1
Median 5Y
2.5
Industry
7.4
Forward
-0.1
vs History
vs Industry
84
Median 3Y
3.1
Median 5Y
3.7
Industry
9.4
vs History
0
vs Industry
26
Median 3Y
-1.4
Median 5Y
-1.6
Industry
4.2
Forward
0.2
vs History
0
vs Industry
24
Median 3Y
-1.2
Median 5Y
-1.6
Industry
4.3
Forward
0.2
vs History
0
vs Industry
22
Median 3Y
-2.6
Median 5Y
-3.3
Industry
5.3
vs History
0
vs Industry
19
Median 3Y
-2.6
Median 5Y
-3.3
Industry
3.3
vs History
vs Industry
73
Median 3Y
1.9
Median 5Y
2.3
Industry
5

Multiples Across Competitors

BNR Competitors Multiples
Burning Rock Biotech Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
74.8m USD 1 -0.8 0.1 0.1
US
Abbvie Inc
NYSE:ABBV
321.6B USD 5.9 66.7 14.3 21.8
US
Amgen Inc
NASDAQ:AMGN
152.2B USD 5.4 22.7 16.7 25
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
107.7B USD 10.9 29.8 23.9 25.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
105.3B USD 8 26.6 18 19.8
US
Gilead Sciences Inc
NASDAQ:GILD
91.3B USD 3.4 16.1 9.6 12.8
AU
CSL Ltd
ASX:CSL
139.1B AUD 6.4 36.7 22.1 27.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
40.7B USD 5.9 -8.6 -9 -7.7
US
Biogen Inc
NASDAQ:BIIB
31.2B USD 3.2 26.9 14.5 18
KR
Celltrion Inc
KRX:068270
41.5T KRW 18 68.8 43.2 56.7
P/E Multiple
Earnings Growth
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
Average P/E: 36.8
Negative Multiple: -0.8
N/A
US
Abbvie Inc
NYSE:ABBV
66.7
403%
US
Amgen Inc
NASDAQ:AMGN
22.7
79%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.8
49%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
16.1
74%
AU
CSL Ltd
ASX:CSL
36.7
83%
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -57.5 N/A
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8.6 N/A
US
Biogen Inc
NASDAQ:BIIB
26.9
152%
KR
Celltrion Inc
KRX:068270
68.8
105%

See Also

Discover More